成人创伤后癫痫发作的药物治疗:英国与爱尔兰共和国当前实践模式调查
该调查由英国神经外科、神经内科、神经重症及康复医学医生组成的协作组于2017年初发起,评估成人创伤性脑损伤(TBI)后癫痫预防用药选择和早期创伤后癫痫发作(PTS)治疗时长的实践差异与不确定性。117名受访者中76%为神经外科医生,来自英国和爱尔兰30所(共32所)收治创伤的医院。结果显示癫痫预防用药使用和PTS治疗时长均存在实践差异与高度不确定性,多数受访者愿意参与未来研究。
要点
- 53%受访者不常规使用癫痫预防用药,38%预防用药1周。
- 62%受访者急性期使用左乙拉西坦治疗癫痫发作,42%总疗程3个月。
- 90%受访者对癫痫发作治疗时长不确定,78%愿意参与进一步研究。
核心结论
- 调查结果显示成人TBI后癫痫预防用药和早期PTS治疗时长两方面实践存在差异和不确定性。
- 多数受访者愿意参与未来研究以帮助解决这一关键问题,显示这两个临床问题的重要性和相关性。
研究设计与样本
- 2017年初成立由神经外科、神经内科、神经重症和康复医学医生组成的协作组。
- 通过在线问卷调查英国和爱尔兰管理TBI患者的临床医生,问卷经英国神经外科医师学会学术委员会批准后通过电子邮件列表发放。
- 共117名受访者回答问卷,以神经外科医生为主(76%),来自英国和爱尔兰30所(共32所)收治创伤的医院。
主要发现
- 53%受访者不常规使用癫痫预防用药,38%预防用药1周。
- 60%受访者认为癫痫预防用药存在不确定性,71%愿意参与进一步研究解决该问题。
- 62%受访者在急性期使用左乙拉西坦治疗癫痫发作,42%总疗程持续3个月。
- 90%受访者对癫痫发作治疗时长不确定,78%愿意参与进一步研究解决该问题。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient selection for seizure prophylaxis after traumatic brain injury (TBI) and duration of anti-epileptic drug treatment for patients with early post-traumatic seizures (PTS), remain plagued with uncertainty. In early 2017, a collaborative group of neurosurgeons, neurologists, neurointensive care and rehabilitation medicine physicians was formed in the UK with the aim of assessing variability in current practice and gauging the degree of uncertainty to inform the design of future studies. Here we present the results of a survey of clinicians managing patients with TBI in the UK and Ireland. MATERIALS AND METHODS: An online survey was developed and piloted. Following approval by the Academic Committee of the Society of British Neurological Surgeons, it was distributed via appropriate electronic mailing lists. RESULTS: One hundred and seventeen respondents answered the questionnaire, predominantly neurosurgeons (76%) from 30 (of 32) trauma-receiving hospitals in the UK and Ireland. Fifty-three percent of respondents do not routinely use seizure prophylaxis, but 38% prescribe prophylaxis for one week. Sixty percent feel there is uncertainty regarding the use of seizure prophylaxis, and 71% would participate in further research to address this question. Sixty-two percent of respondents use levetiracetam for treatment of seizures during the acute phase, and 42% continued for a total of 3 months. Overall, 90% were uncertain about the duration of treatment for seizures, and 78% would participate in further research to address this question. CONCLUSION: The survey results demonstrate the variation in practice and uncertainty in both described aspects of management of patients who have suffered a TBI. The majority of respondents would want to participate in future research to help try and address this critical issue, and this shows the importance and relevance of these two clinical questions.
引用
- Mee H, Kolias AG, Chari A, et al. Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland. Acta Neurochir (Wien). 2018. PMID: 30276544. doi:10.1007/s00701-018-3683-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。